WEDNESDAY, Sept. 20, 2023 (HealthDay News) — In a surprising move, the U.S. Food and Drug Administration (FDA) has opted not to approve a needle-free alternative to the EpiPen for emergency treatment of severe allergic reactions. Approval of the Neffy nasal spray was widely anticipated. An FDA advisory panel votedContinue Reading

MONDAY, Aug. 7, 2023 (HealthDay News) — Early and gradual exposure to peanuts under medical supervision curbed infants’ allergies, according to a new study. While researchers had seen that peanut oral immunotherapy was well tolerated by toddlers, this research focused on an even younger age group. “We’ve seen how peanutContinue Reading

FRIDAY, May 12, 2023 (HealthDay News) — Outside advisors for the U.S. Food and Drug Administration voted Thursday to recommend approval of Neffy, the first epinephrine nasal spray for severe allergic reactions. Although most of the Pulmonary-Allergy Drugs Advisory Committee members supported the spray for adults (16:6) and children (17:5),Continue Reading